Quote:
Originally Posted by carriebft 
http://www.biomedcentral.com/1471-2334/9/45/#B14http://www.ncbi.nlm.nih.gov/pubmed/1...,f1000m,isrctnhttp://iai.asm.org/cgi/content/full/75/6/2650
Those are just a few papers that demonstrate how Inside Vaccines is cherry picking.
Also you see that they take phrases from studies that say things like "hia now accounts for X% of all Hi meningitis cases" when that is obviously going to be the case when you knock out the #1.
So if prevaccine there were 100 hib cases and 10 hia cases causing meningitis with a total meningitis due to Hi number of 120. If post vaccine you have 0 hib, still 10 hia and 20 total cases...well...I think you get the point. This is the case in the second paper I linked.
Again, I am not saying they are totally wrong; I am saying they are cherry picking and not giving the whole picture. The third link is one I feel gives more of the truth of the matter (though it is earlier than the germany paper and also a fwe other papers looking at those minority populations most susceptible to hia- see second paper- so it doesn't include that information) but it still gives a more com plete picture. It also mentions pretty steady rates in USA despite vaccine use.
ETA: on the point of "other ways to kill a person"- obviously this is true. But agreeing with you on this point does not mean I agree that hia and hib are equal in virulence.
|
It's NTHi that primarily replaces Hib. The only reference you linked to that addresses that one is the first, and in Germany, Half their isolates are were still Hib, and they only looked at children under 10. Replacement only is observed when "herd immunity" to Hib kicks in and you look at invasive disease across the whole population.
But even there, look at the numbers here:
http://www.biomedcentral.com/1471-2334/9/45/figure/F1
In years where fewer type B isolates were recovered, there were more (absolute, not relative) NTHi (aka, unencapsulated) strains recovered, and visa versa.
This is evidence
for, not against, replacement.